Search results
Results from the WOW.Com Content Network
The type of complications depend on the treatment modality used: Urinary incontinence can happen after prostate surgery, especially stress urinary incontinence. The prostate is located right beneath the bladder, and surrounds the urethral sphincter. Any damage to the sphincter or surrounding muscles and nerves can lead to urinary incontinence.
Things to avoid if you have symptoms of an enlarged prostate, according to the NHS in England [11]. Lifestyle alterations to address the symptoms of BPH include physical activity, [ 59 ] decreasing fluid intake before bedtime, moderating the consumption of alcohol and caffeine-containing products and following a timed voiding schedule.
Transurethral microwave thermotherapy is a non-surgical, minimally invasive therapy that can be performed under a local anesthetic on an outpatient basis. The treatment involves inserting a special microwave urinary catheter into the hyperplastic prostatic urethra.
Here's what you need to know to avoid complications. For premium support please call: 800-290-4726 more ways to reach us
Option Grid is the name for a tool for patients and providers to use together when they are discussing and deciding what best to do about possible options, either treatments or tests.
Bleeding may be reduced by pre-treatment with an anti-androgen such as finasteride [6] [7] [8] or flutamide. [citation needed] Clot retention and clot colic. The blood released from the resected prostate may become stuck in the urethra and can cause pain and urine retention. Bladder wall injury, such as perforation (rare).
Prostatic congestion is a medical condition of the prostate gland that happens when the prostate becomes swollen by excess fluid and can be caused by prostatitis.The condition often results in a person with prostatic congestion feeling the urge to urinate frequently.
Dutasteride is used for treating BPH, colloquially known as an "enlarged prostate". [ 9 ] [ 14 ] It is approved by the Food and Drug Administration (FDA) in the U.S. for this indication. [ 15 ] A 2010 Cochrane review found a 25–26% reduction in the risk of developing prostate cancer with 5α-reductase inhibitor chemoprevention .